Bionomics Limited (BNOX)
0.2531
+0.0110 (4.59%)
Inactive · Last trade price on Dec 23, 2024
Bionomics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Cash & Equivalents | 8.08 | 12.61 | 12.1 | 33.56 | 28.5 | 4.58 |
Cash & Short-Term Investments | 8.08 | 12.61 | 12.1 | 33.56 | 28.5 | 4.58 |
Cash Growth | -33.22% | 4.17% | -63.94% | 17.77% | 522.56% | -67.27% |
Accounts Receivable | - | - | - | - | 0.19 | 0.02 |
Other Receivables | 0.12 | 0.13 | 0.43 | 6.78 | 0.94 | 2.96 |
Receivables | 0.12 | 0.13 | 0.43 | 6.78 | 1.13 | 2.98 |
Prepaid Expenses | 0.23 | 0.46 | 0.8 | 1.46 | 0.86 | 0.77 |
Restricted Cash | - | - | - | - | 0.44 | - |
Total Current Assets | 8.43 | 13.19 | 13.33 | 41.81 | 30.93 | 8.33 |
Property, Plant & Equipment | 0.2 | 0.22 | 0.33 | 0.67 | 0.87 | 1.05 |
Goodwill | 8.9 | 8.69 | 8.69 | 12.87 | 12.4 | 12.87 |
Other Intangible Assets | 5.3 | 5.47 | 6.13 | 9.84 | 9.95 | 11.77 |
Other Long-Term Assets | 0.08 | 0.08 | 0.08 | 0.12 | 0.12 | 0.44 |
Total Assets | 22.92 | 27.65 | 28.56 | 65.31 | 54.26 | 34.46 |
Liabilities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Accounts Payable | 1.33 | 2.24 | 1.44 | 1.56 | 1.03 | 1.26 |
Accrued Expenses | 1.1 | 1.46 | 1.19 | 1.64 | 1.16 | 1.06 |
Current Portion of Long-Term Debt | - | - | - | - | - | 5.19 |
Current Portion of Leases | 0.13 | 0.12 | 0.11 | 0.16 | 0.17 | 0.77 |
Total Current Liabilities | 2.55 | 3.83 | 2.74 | 3.36 | 2.36 | 8.27 |
Long-Term Debt | - | - | - | - | - | 6.26 |
Long-Term Leases | 0.09 | 0.12 | 0.24 | 0.53 | 0.69 | 0.03 |
Long-Term Deferred Tax Liabilities | 0.83 | 0.96 | 1.1 | 1.8 | 1.84 | 2.2 |
Other Long-Term Liabilities | 2.37 | 5.25 | 2.47 | 2.7 | 1.76 | 4.98 |
Total Liabilities | 5.85 | 10.16 | 6.55 | 8.4 | 6.67 | 21.78 |
Shareholders' Equity
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Common Stock | - | - | - | 217.7 | 190.19 | 148.16 |
Additional Paid-In Capital | 198.28 | 198.48 | 187.55 | - | - | - |
Retained Earnings | -178.78 | -177.98 | -162.48 | -173.31 | -154.04 | -148.89 |
Comprehensive Income & Other | -2.43 | -3.01 | -3.06 | 12.52 | 11.45 | 13.41 |
Shareholders' Equity | 17.07 | 17.49 | 22.01 | 56.91 | 47.6 | 12.68 |
Total Liabilities & Equity | 22.92 | 27.65 | 28.56 | 65.31 | 54.26 | 34.46 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Total Debt | 0.22 | 0.24 | 0.35 | 0.69 | 0.87 | 12.24 |
Net Cash (Debt) | 7.86 | 12.37 | 11.75 | 32.87 | 27.63 | -7.66 |
Net Cash Growth | -33.08% | 5.27% | -64.26% | 18.96% | - | - |
Net Cash Per Share | 0.67 | 1.24 | 1.44 | 4.37 | 6.38 | -2.53 |
Filing Date Shares Outstanding | 19.53 | 17.32 | 8.16 | 7.52 | 5.6 | 3.48 |
Total Common Shares Outstanding | 17.32 | 13.25 | 8.16 | 7.52 | 5.6 | 3.48 |
Working Capital | 5.88 | 9.36 | 10.59 | 38.45 | 28.57 | 0.06 |
Book Value Per Share | 0.99 | 1.32 | 2.70 | 7.57 | 8.50 | 3.65 |
Tangible Book Value | 2.86 | 3.33 | 7.19 | 34.21 | 25.25 | -11.96 |
Tangible Book Value Per Share | 0.17 | 0.25 | 0.88 | 4.55 | 4.51 | -3.44 |
Machinery | - | - | - | - | 0.11 | 1.37 |